Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study.
about
Combined oral contraceptives: the risk of myocardial infarction and ischemic strokeCombined oral contraceptives: venous thrombosisDifferent combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysisHormonal contraceptives: pharmacology tailored to women's healthHormonal contraception and venous thromboembolismVenous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies.Novel effects of hormonal contraceptive use on the plasma proteome.Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review.Dangerous triplet: Polycystic ovary syndrome, oral contraceptives and Kounis syndrome.Detecting adverse drug reactions following long-term exposure in longitudinal observational data: The exposure-adjusted self-controlled case series.Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databasesRisk of venous thromboembolism with oral contraceptives.Fourth-Generation Progestins Inhibit 3β-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids.The Risk of Venous Thromboembolism Associated with Oral Contraceptive; the Search Is Still On.Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.Pulmonary embolism and deep vein thrombosis related to oral contraceptive use.Exposure to combined oral contraceptives and risk of venous thromboembolism: a protocol for nested case-control studies using the QResearch and the CPRD databasesComprehensive evaluation of Safyral(®) 2012.Toward a new concept of "natural balance" in oral estroprogestin contraception.Hormonal contraception, thrombosis and age.European society of contraception statement on contraception in obese women.Tyrosine kinase-targeting drugs-associated heart failure.Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.A survey of bonobo (Pan paniscus) oral contraceptive pill use in North American zoos.Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study.A 55-Year Old Man with Acute Painful Flank Mass, a Case Report.Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives.Risks of thromboembolism associated with hormone contraceptives in Japanese compared with Western women.Effect of Progesterone and Synthetic Progestins on Whole Blood Clot Formation and Erythrocyte Structure.Synthetic Hormones and Clot Formation.Drospirenone enhances GPIb-IX-V-mediated platelet activation.2013 ESH/ESC Guidelines for the management of arterial hypertensionDrospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?
P2860
Q24187746-167D59D4-D968-4D05-8954-0BDF7F68D1B3Q24198113-F4CDDF81-8B5C-40ED-AAF6-964EA8C40A0DQ24624180-442A3E9D-8916-4F70-91FF-A88CF56DBE3DQ26745814-1C97931C-FF11-4BB3-906C-E69B1E1A03EDQ28266187-0DEC45F8-B954-4E4C-A08D-A67B886DBAECQ28266410-4504A35D-4CB2-4D3A-BCFB-174805164762Q30235365-9355E482-CB6F-43B3-BF6E-B1745146338CQ34416417-D98955B4-6DA5-4E81-B691-AD82B55AE330Q34636421-AF3486F1-1E74-4E87-A173-3075B15F7B4CQ34780146-315D2568-3C7A-43E9-AC96-731D527C27D6Q35135876-FFD1B1AD-3D29-448B-8363-44D26E9FB619Q35651010-11D8DA6D-C0AD-4FF8-9B6B-9A86D567476FQ35664032-A2BC17D7-5E89-4923-BA62-68D298FC9D5CQ36153866-EF399A4C-6A9C-4D8D-828F-3D8B2EF48022Q36188121-205BB41A-0267-4F5E-85D9-A13B20B6AD03Q36887503-CE421A3D-DD39-4C94-8B75-7E28DCE31142Q37200032-DD3C7E71-7545-4CFB-BFAD-C21CA97B7EA4Q37704438-CDE16756-BB99-4F02-83CE-4555E71A89DBQ38062561-3D8E3C5B-3EF2-42AD-A11F-BDCB645713ACQ38127769-C5E4B3DB-6A84-47B3-A2A1-A32F4C5FA5F7Q38250178-0694A92E-056E-4803-B04C-1FA4EC66FA69Q38266121-5304D833-F53F-41B3-AF6B-F704B36324BEQ38401605-AC63508F-EC11-4ACD-B346-80257486A0AFQ38501601-B864E80B-E4C6-446F-982E-AF7CB98D0D06Q38851182-6A4F2AAF-7DE8-4F77-A85C-BE0D58071B96Q39550818-AD45B746-A627-4F96-A320-1E9EF6FC5C3AQ40553746-707B52AD-3049-43A9-9E98-0DB773E2DE45Q43207510-698F1ED2-0480-42DE-8FB3-AB361E05811AQ46632887-BEA35651-3F1B-490D-BD3B-C7E5DFB4E1A0Q47952356-B9935126-33E6-4DB4-B167-EF6BA20A8F88Q51827826-2CC36C60-EB3B-4D5A-8B21-81A03B16936BQ52871993-D8247694-0C85-4D05-8247-16430FE5733CQ53051354-9D455B00-5A7E-49B7-8C8B-11CD5776C4F9Q53584129-11F55717-FBEF-48E0-9E95-A80ECD437BA1Q56970511-4CECAE54-4938-4BF0-9034-10CD61D29FD7Q57446582-D886BE03-660F-41F3-A4BC-703DEC94E393
P2860
Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Higher risk of venous thrombos ...... population-based cohort study.
@ast
Higher risk of venous thrombos ...... population-based cohort study.
@en
type
label
Higher risk of venous thrombos ...... population-based cohort study.
@ast
Higher risk of venous thrombos ...... population-based cohort study.
@en
prefLabel
Higher risk of venous thrombos ...... population-based cohort study.
@ast
Higher risk of venous thrombos ...... population-based cohort study.
@en
P2860
P356
P1476
Higher risk of venous thrombos ...... population-based cohort study
@en
P2093
Naomi Gronich
P2860
P304
P356
10.1503/CMAJ.110463
P407
P50
P577
2011-11-07T00:00:00Z